Yaraş, S.; Özdoğan, O.; Tezcan Ülger, S.; Aslan, G.; Tiftik, E.N.; Sezgin, O.
Hepatitis E Virus (HEV) Seroprevalence in Cryptogenic Cirrhosis: From Evidence of High Frequency to the Impact on Disease Progression. Medicina 2025, 61, 2014.
https://doi.org/10.3390/medicina61112014
AMA Style
Yaraş S, Özdoğan O, Tezcan Ülger S, Aslan G, Tiftik EN, Sezgin O.
Hepatitis E Virus (HEV) Seroprevalence in Cryptogenic Cirrhosis: From Evidence of High Frequency to the Impact on Disease Progression. Medicina. 2025; 61(11):2014.
https://doi.org/10.3390/medicina61112014
Chicago/Turabian Style
Yaraş, Serkan, Osman Özdoğan, Seda Tezcan Ülger, Gönül Aslan, Eyüp Naci Tiftik, and Orhan Sezgin.
2025. "Hepatitis E Virus (HEV) Seroprevalence in Cryptogenic Cirrhosis: From Evidence of High Frequency to the Impact on Disease Progression" Medicina 61, no. 11: 2014.
https://doi.org/10.3390/medicina61112014
APA Style
Yaraş, S., Özdoğan, O., Tezcan Ülger, S., Aslan, G., Tiftik, E. N., & Sezgin, O.
(2025). Hepatitis E Virus (HEV) Seroprevalence in Cryptogenic Cirrhosis: From Evidence of High Frequency to the Impact on Disease Progression. Medicina, 61(11), 2014.
https://doi.org/10.3390/medicina61112014